European Society of Toxicology In Vitro > News > PAROPEDIA NEWSLETTER #4 – EDITORIAL BY ESTIV PRESIDENT DR.HELENA KANDAROVA
28 February 2025

PAROPEDIA NEWSLETTER #4 – EDITORIAL BY ESTIV PRESIDENT DR.HELENA KANDAROVA

The latest editorial for PARCOpedia by ESTIV President Dr. Helena Kandarova highlights the crucial role of collaborative platforms like PARCopedia in advancing Next-Generation Risk Assessment (NGRA) and New Approach Methodologies (NAMs). With over 25 years of experience in NAMs for regulatory applications, Dr. Kandarova reflects on the power of interdisciplinary cooperation in shaping the future of chemical safety assessment.

The editorial discusses key milestones, including the PARC session at ESTIV 2024, the growing ESTIV-PARC collaboration, and exciting developments such as the affiliation of SAAOP with ESTIV and ASCCT. It also extends an open invitation to researchers and regulators to contribute to ESTIV 2026 in Maastricht, shaping an impactful scientific program dedicated to NAM implementation.

Join Parcopedia to read the full editorial [here] and become part of the transformation in chemical risk assessment!

Related content

ESTIV – ASCCT Webinar: NAMs and Medical Devices – Challenges and Successes

We are thrilled to have Kelly Coleman, PhD, DABT, and Lindsey Borton, MPH, DABT…

2026 ESTIV Applied Training Course – the early-bird registration deadline is approaching!

The deadline for the reduced registration fee is approaching fast — 31 July is the last day! 🚨

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

Silver Sponsor

Communication partners

Memorandum of Understanding